We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIV icon
1201
Telefônica Brasil
VIV
$22.4B
-12,578
Closed -$138K
WAFD icon
1202
WaFd
WAFD
$2.72B
-6,173
Closed -$203K
WAL icon
1203
Western Alliance Bancorporation
WAL
$9.07B
-3,815
Closed -$251K
JBTM
1204
JBT Marel
JBTM
$7.14B
-2,017
Closed -$201K
CBAY
1205
DELISTED
Cymabay Therapeutics
CBAY
-26,263
Closed -$620K
KRTX
1206
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-6,895
Closed -$2.18M
SPLK
1207
DELISTED
Splunk Inc
SPLK
-13,041
Closed -$1.99M
IMGN
1208
DELISTED
Immunogen Inc
IMGN
-54,327
Closed -$1.61M
NTCO
1209
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
-15,230
Closed -$104K
MRTX
1210
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-25,078
Closed -$1.47M
DOC
1211
DELISTED
PHYSICIANS REALTY TRUST
DOC
-12,402
Closed -$165K

Similar funds

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.